Skip to main content

Table 2 Patterns of vaccine administration in the rotavirus vaccinated cohort

From: Effectiveness of rotavirus vaccines, licensed but not funded, against rotavirus hospitalizations in the Valencia Region, Spain

Rotavirus vaccination RV1 RV5
First dose n = 24,723 n = 53,558
  Week of age at vaccination (median; IQR) 9 (9–11) 9 (9–10)
  Dose administration >12 weeksa (n; %) 5,263 (21%) 6,515(12%)
Second dose n = 21,119 n = 44,995
  Week of age at vaccination (median; IQR) 18 (17–19) 17 (15–18)
  Dose administration >24 weeksb (n; %) 1,172 (6%) -
  1st - 2nd dose interval in weeks (median; IQR) 9 (8–9) 8 (5–9)
  1st - 2nd dose interval 22–27 days (n; %) 213 (1%) 1,162 (3%)
Third dose - n = 34,865
  Week of age at vaccination (median; IQR) - 26 (19–27)
  Dose administration >32 weeksc (n; %) - 179 (1%)
  2nd – 3rd dose interval in weeks (median; IQR) - 8 (5–9)
  2nd – 3rd dose interval 22–27 days (n; %) - 1,338 (4%)
  1. a>84 days; b>168 days; c>224 days.